Aiforia's collaboration with Paris Hospital District moves forward

Translation: Original comment published in Finnish on 9/5/2024 at 12:13 noon EEST.

The start of the collaboration was announced earlier this spring, so the press release comes as no surprise, although the agreement announced now provides a concrete indication of the first steps of the collaboration. According to the release, the collaboration at this stage includes the use of Aiforia's AI solutions in the analysis of tissue samples from prostate cancer patients and the use of Aiforia's AI model development software. Aiforia will be deployed at the pathology department of the Bicetre Hospital (AP-HP Paris Saclay University), which has been a pilot site for digital pathology in France since 2018.

The clinical use of Aiforia in Paris will start on a somewhat smaller scale (1/5 of the current CE-marked AI models), so revenue streams from the customer are expected to be slow. The contract partner, Assistance Publique–Hôpitaux de Paris (AP-HP), is a university hospital group with 38 hospitals in the Paris region, serving 8 million patients per year. Thus, the potential for expansion in this hospital group alone is significant. In addition, Aiforia will be able to demonstrate its product capabilities directly at the heart of the digitization of French pathology and is well positioned to take a significant market share in France, making the collaboration strategically valuable in the longer term. Our forecasts have already included this account and require Aiforia to continue to deliver new customer wins and customer deployment progress, so the release has no impact on our forecasts or our view of the company.